[1]谢佳 唐红 徐婷 边叶婷.心肺运动试验在右心疾病中的应用[J].心血管病学进展,2021,(10):873.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.003]
　XIE JiaTANG HongXU TingBIAN Yeting.Application of Cardiopulmonary Exercise Test in Right Heart Disease[J].Advances in Cardiovascular Diseases,2021,(10):873.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.003]
点击复制

心肺运动试验在右心疾病中的应用()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年10期
页码:
873
栏目:
综述
出版日期:
2021-10-25

文章信息/Info

Title:
Application of Cardiopulmonary Exercise Test in Right Heart Disease
作者:
谢佳 唐红 徐婷 边叶婷
(四川大学华西医院心内科,四川 成都 610041)
Author(s):
XIE JiaTANG HongXU TingBIAN Yeting
(Department of CardiologyWest China HospitalSichuan UniversityChengdu 610041SichuanChina)
关键词:
心肺运动试验; 右心疾病; 肺动脉高压; 法洛四联症; 致心律失常性右室心肌病; 三尖瓣下移畸形
Keywords:
Cardiopulmonary exercise testing; Right heart disease; Pulmonary hypertension; Tetralogy of fallot; Arrhythmogenic right ventricular cardiomyopathy; Ebsteins anomaly
DOI:
10.16806/j.cnki.issn.1004-3934.2021.10.003
摘要:
心肺运动试验可量化评估心肺功能，是一种可同时反映心肺代谢及整体功能的无创检查方法，已广泛用于心血管疾病的诊断、危险分层、疗效评价、预后评估和康复指导等。右心疾病在心肺疾病的发病率和死亡率中占重要地位，现就心肺运动试验在右心疾病中的应用做一综述。
Abstract:
Cardiopulmonary exercise testing quantified the assessment of cardiopulmonary function. It is a non-invasive test that can simultaneously reflect the cardiopulmonary function and overall function. It has been widely used in diagnosis,risk stratification，prognosis evaluation and cardiopulmonary rehabilitation guidance of cardiovascular disease. Right heart disease plays an important role in the morbidity and mortality of cardiopulmonary disease. This paper reviews the application of cardiopulmonary exercise testing in right heart disease

参考文献/References:


[1] Guazzi M,Bandera F,Ozemek C,et al. Cardiopulmonary exercise testing[J]. J Am Coll Cardiol,2017,70(13):1618-1636.

[2] Tran D. Cardiopulmonary exercise testing[J]. Methods Mol Biol,2018,1735:285-295.

[3] Galiè N, Humbert M, Vachiery JL,et al. 2015 ESC/ ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:The Joint Task Force for the Diagnosis and T reatment of Pulmonary Hypertension of the European Society of Cardiology ( ESC ) and the European Respiratory Society(ERS):Endorsed by:Association for European Paediatric and Congenital Cardiology (AEPC),International Society for Heart and Lung T ransplantation (ISHLT)[J]. Eur Heart J,2015,37(1):67-119.

[4] Paolillo S,Farina S,Bussotti M,et al. Exercise testing in the clinical management of patients affected by pulmonary arterial hypertension[J]. Eur J Prev Cardiol,2012,19(5): 960-971.

[5] Pinkstaff SO,Burger CD,Daugherty J,et al.Cardiopulmonary exercise testing in patients with pulmonary hypertension:clinical recommendations based on a review of the evidence [J]. Expert Rev Respir Med,2016,10(3):279-295.

[6] Ramos RP,Ferreira EVM,Valois FM,et al. Clinical usefulness of end-tidal CO2 profiles during incremental exercise in patients with chronic thromboembolic pulmonary hypertension[J].Respir Med ,2016,11(120):70-77.

[7] Shi X,Guo J,Gong S,et al. Oxygen uptake is more effificient in idiopathic pulmonary arterial hypertension than in chronic thromboembolic pulmonary hypertension[J]. Respirology,2016,21(1):149-156.

[8] 姚芳,刘锦名,许齐,等.慢性阻塞性肺疾病伴肺动脉高压对运动中气体交换的影响[J]. 心肺血管病杂志,2016,5(35):348-351.

[9] Raeside DA,Smith A,Brown A,et al. Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension[J]. Eur Respir J,2000,16(2):282-287.

[10] Schwaiblmair M,Faul C,von Scheidt W,et al. Detection of exercise-induced pulmonary arterial hypertension by cardiopulmonary exercise testing[J]. Clin Cardiol,2012,35(9):543-558.

[11] Yasunobu Y,Oudiz R,Sun X,et al. End-tidal PCO 2 abnormality and exercise limitation in patients with primary pulmonary hypertension[J]. Chest ,2005,127 (5):1637-1646.

[12] Oudiz R,Midde R,Hovenesyan A,et al. Usefulness of right- to-left shunting and poor exercise gas exchange for predicting prognosis in patients with pulmonary arterial hypertension[J]. Am J Cardiol,2010,105(8):1186-1191.

[13] Wensel R,Opitz C F,Anker S D,et al. Assessment of survival in patients with primary pulmonary hypertension[J]. Circulation,2002,106(3):319-324.

[14] Deboeck G,Scoditti C,Huez S,et al. Exercise testing to predict outcome in idiopathicversus associated pulmonary arterial hypertension[J]. Eur Respir J,2012,40(6):1410-1419.

[15] 唐毅,柳志红,方丕华,等.峰值循环泵功能预测特发性肺动脉高压预后[J]. 中国循环杂志,2017,5(32):367-371.

[16] 王作刚,赵子梁,黄洋,等.心肺运动试验参数预测慢性血栓栓塞性肺动脉高压患者心输出量的性别差异性[J]. 国际呼吸杂志,2020,6(40):411-416.

[17] Xi Q,Zhao Z,Liu Z,et al. The lowest VE/VCO2 Ratio best identifies chronic thromboembolic pulmonary hypertension[J]. Thromb Res,2014,134(6):1208-1213.

[18] Russell S,Beghetti M,Oudiz R,et al. Effects of oral sildenafil on exercise capacity in children with pulmonary arterial hypertension: a randomised trial[J].Open heart,2019,6(2):e1149.

[19] Akihiro H,Shiro A,Yoshihisa N,et al. Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension:an endothelin receptor antagonist improves the peak PETCO２[J]. 2014,118(2):379-403.

[20] Akihiro H,Shiro A,Yoshihisa N,et al. Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension :an endothelin receptor antagonist improves the peak PETCO2[J]. 2014,118(2):379-403.

[21] Fox B,Kassirer M,Weiss I,et al. Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension[J]. J Card Fail ,2011,17(3):196-200.

[22] 赵十妹,杨媛华,邝土光,等. 肺动脉高压患者运动训练方法的研究[J]. 国际呼吸杂志,2018,38(16):1250-1255.

[23] Task Force Italian Working Group on Rehabilitation and Prevetion (Gruppo Italiano di Gardiologia Riabilitativae Prevenzione,GICR);Working Group on Rehabilitation and Exercise Physiology of the European Society of Cardiology. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricle dysfunction recommendation for performance and interpretation Part Ⅲ:interpretation of cardiopulmonary exercise testing in chronic heart failure and future application[J]. Eur J Cardiovarsc Pre Rehabil,2006,13(4):485-494.

[24] 罗勤,柳志红,马秀平,等.心肺运动试验在评价肺动脉高压患者心功能的应用[J]. 中华心血管杂志.2013,41(6):497-500.

[25] Brown MB,Kempf A,Collins C M,et al. A prescribed walking regimen plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study[J]. Pulm Circ,2017,8(1):1568803746.

[26] Hickey EJ,Veldtman G,Bradley TJ,et al. Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades[J]. Eur J Cardio-Thorac,2009,35(1):156-164.

[27] Rashid I,Mahmood A,Ismail TF,et al. Right ventricular systolic dysfunction but not dilatation correlates with prognostically significant reductions in exercise capacity in repaired Tetralogy of Fallot[J]. 2020,21(8):906-913.

[28] Bhatt SM,Elci OU,Wang Y,et al. Determinants of exercise performance in children and adolescents with repaired tetralogy of fallot using stress echocardiography[J]. Pediatr Cardiol,2019,40(1):71-78.

[29] D?u?niewska N,Podolec P,Miszalski-Jamka T,et al. Effect of ventricular function and volumes on exercise capacity in adults with repaired Tetralogy of Fallot[J]. Indian Heart J,2018,70(1):87-92.

[30] Lumens J,Fan CS,Walmsley J,et al. Relative impact of right ventricular electromechanical dyssynchrony versus pulmonary regurgitation on right ventricular dysfunction and exercise intolerance in patients after repair of Tetralogy of Fallot[J]. J Am Heart Assoc,2019,8(2):e10903.

[31] Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support[J]. J Cardiovasc Magn Reson,2011,13(1):9.

[32] Babu-Narayan SV,Diller G,Gheta RR,et al. Clinical outcomes of surgical pulmonary valve replacement after repair of Tetralogy of Fallot and potential prognostic value of preoperative cardiopulmonary exercise testing[J]. Circulation,2014,129(1):18-27.

[33] Giardini A,Specchia S,Tacy TA,et al. Usefulness of cardiopulmonary exercise to predict long-term prognosis in adults with repaired Tetralogy of Fallot[J]. Am J Cardiol,2006,99(10):1462-1467.

[34] Müller J,Hager A,Diller GP,et al. Peak oxygen uptake,ventilatory efficiency and QRS-duration predict event free survival in patients late after surgical repair of tetralogy of Fallot[J]. Int J Cardiol,2015,196:158-164.

[35] Shafer KM,Opotowsky AR,Rhodes J. Exercise testing and spirometry as predictors of mortality in congenital heart disease:Contrasting Fontan physiology with repaired tetralogy of Fallot[J]. Congenit Heart Dis,2018,13(6):903-910.

[36] Yang M,Chen C,Chiu H,et al. Assessing utility of exercise test in determining exercise prescription in adolescent and adult patients with repaired tetralogy of fallot[J]. Heart Vessels ,2017,32(2):201-207.

[37] Scheel PJ 3rd ,Florido R,Hsu S,et al. Safety and utility of cardiopulmonary exercise testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia[J]. J Am Heart Assoc,2018,24(8):1-12.

[38] Kühn A,de Pasquale Meyer G,Müller J,et al. Tricuspid valve surgery improves cardiac output and exercise performance in patients with Ebstein’s anomaly[J]. Int J Cardiol,2013,166(2):494-498.

[39] Meierhofer C,Kühn A,Müller J,et al. Non-invasive hemodynamic CMR parameters predicting maximal exercise capacity in 54 patients with Ebstein’s anomaly[J]. Pediatr Cardiol,2019,40(4):792-798.

[40] Radojevic J,Inuzuka R,Alonso-Gonzalez R,et al. Peak oxygen uptake correlates with disease severity and predicts outcome in adult patients with Ebstein’s anomaly of the tricuspid valve[J]. Int J Cardiol,2013,163(3):305-308.

相似文献/References:

[1]蒋昭隆,刘剑雄.心肺运动试验在心脏瓣膜病的运用现状[J].心血管病学进展,2019,(6):951.[doi:10.16806/j.cnki.issn.1004-3934.201.06.028]
　JIANG Zhaolong,LIU Jianxiong.Application of Cardiopulmonary Exercise Test in Cardiac Valvular Disease[J].Advances in Cardiovascular Diseases,2019,(10):951.[doi:10.16806/j.cnki.issn.1004-3934.201.06.028]
[2]蒋昭隆刘剑雄.心肺运动试验在冠心病运用现状[J].心血管病学进展,2019,(9):1290.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.027]
　JIANG Zhaolong,LIU Jianxiong.Current Status of Cardiopulmonary Exercise Test in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(10):1290.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.027]
[3]张毅 罗勤 赵智慧 赵青 柳志红.心肺运动试验应用于系统性硬化病相关肺动脉高压筛查的研究进展[J].心血管病学进展,2021,(7):577.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.001]
　ZHANG Yi,LUO Qin,ZHAO Zhihui,et al.Cardiopulmonary Exercise Test for Screening of Systemic Sclerosis-Associated Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2021,(10):577.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.001]
[4]宋燕新 刘萍 赵威.分钟通气量和二氧化碳生成量关系对于心力衰竭患者的价值[J].心血管病学进展,2022,(5):419.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.009]
　SONG Yanxin,LIU Ping,ZHAO Wei.Value of the Relationship of VE and VCO2 in Heart Failure Patients[J].Advances in Cardiovascular Diseases,2022,(10):419.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.009]
[5]应桃 吴镜.心肺运动试验在呼吸系统疾病中的应用[J].心血管病学进展,2023,(4):365.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.017]
　YING Tao,WU Jing.Application of Cardiopulmonary exercise testing in respiratory disease[J].Advances in Cardiovascular Diseases,2023,(10):365.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.017]

更新日期/Last Update: 2021-12-02